Literature DB >> 19962246

Tobacco addiction: a biochemical model of nicotine dependence.

Marcelo O Ortells1, Georgina E Barrantes.   

Abstract

Nicotine is the main psychoactive substance present in tobacco, targeting in the CNS the nicotinic acetylcholine receptors (nAChR). The main effects of nicotine associated with smoking are nAChR upregulation, nAChR desensitization and modulation of the dopaminergic system. However, there is a lack of a comprehensive explanation of their roles that effectively makes clear how nicotine dependence might be established on those grounds. Receptor upregulation is an unusual effect for a drug of abuse, because theoretically this implies less need for drug consumption. Receptor upregulation and receptor desensitization are commonly viewed as opposite, homeostatic mechanisms. We here analyze the available information under a model in which both receptor upregulation and receptor desensitization are responsible for establishing a mechanism of nicotine dependence, consequently having an important role in starting and maintaining tobacco addiction. We propose that negative feedbacks on dopamine release regulated by alpha4beta2 nAChRs are disrupted by nicotine. nAChR desensitization is the disrupting mechanism, while nAChR upregulation is the reinforcing process of nicotine dependence, which eventually initiates tobacco addiction. A conclusion of the model is that drugs used for smoking cessation should inhibit preferentially alpha4beta2 nAChRs and to have a low or null ability to upregulate nAChRs, as this characteristic allows the smoker to achieve downregulation without abstinence symptoms. A relationship between this hypothesis and smoking and schizophrenia is also discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962246     DOI: 10.1016/j.mehy.2009.11.004

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

Review 1.  Enhanced Sensory-Cognitive Processing by Activation of Nicotinic Acetylcholine Receptors.

Authors:  Susan M Gil; Raju Metherate
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

2.  Physiological effects of cigarette smoking in the limbic system revealed by 3 tesla magnetic resonance spectroscopy.

Authors:  Angelika Mennecke; Andrea Gossler; Thilo Hammen; Arnd Dörfler; Andreas Stadlbauer; Julie Rösch; Johannes Kornhuber; Stefan Bleich; Marc Dölken; Norbert Thürauf
Journal:  J Neural Transm (Vienna)       Date:  2014-03-19       Impact factor: 3.575

3.  Nicotine-induced enhancement of responding for conditioned reinforcement in rats: role of prior nicotine exposure and α4β2 nicotinic receptors.

Authors:  Elizabeth Glenn Guy; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

4.  Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.

Authors:  G Patrick Hussmann; Kristen E DeDominicis; Jill R Turner; Robert P Yasuda; Jacquelyn Klehm; Patrick A Forcelli; Yingxian Xiao; Janell R Richardson; Niaz Sahibzada; Barry B Wolfe; Jon Lindstrom; Julie A Blendy; Kenneth J Kellar
Journal:  J Neurochem       Date:  2014-02-07       Impact factor: 5.372

5.  Cholinergic Synaptic Homeostasis Is Tuned by an NFAT-Mediated α7 nAChR-Kv4/Shal Coupled Regulatory System.

Authors:  Abdunaser Eadaim; Eu-Teum Hahm; Elizabeth D Justice; Susan Tsunoda
Journal:  Cell Rep       Date:  2020-09-08       Impact factor: 9.423

6.  Glutamatergic and GABAergic metabolism in mouse brain under chronic nicotine exposure: implications for addiction.

Authors:  Mohammad Shameem; Anant Bahadur Patel
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

7.  Effect of traumatic brain injury on nicotine-induced modulation of dopamine release in the striatum and nucleus accumbens shell.

Authors:  Yuan-Hao Chen; Tung-Tai Kuo; Eagle Yi-Kung Huang; Yu-Ching Chou; Yung-Hsiao Chiang; Barry J Hoffer; Jonathon Miller
Journal:  Oncotarget       Date:  2018-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.